Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Pareek

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Congestive heart failure: More common as well as an important cardiovascular outcomeAnil Pareek
Current Medical Research and Opinion|May 29, 2015
Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66Anil Pareek
Annals of the Rheumatic Diseases|December 24, 2016
Statin therapy now more common than steroids in clinical practiceAnil Pareek, Nitin Chandurkar
Current Medical Research and Opinion|April 16, 2013
Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritisAnil Pareek, Nitin Chandurkar
The Lancet. Diabetes & Endocrinology|January 3, 2016
Drug approvals in IndiaAnil Pareek, Nitin Chandurkar
The New England Journal of Medicine|November 3, 2016
Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesAnil Pareek, Nitin Chandurkar, Kumar Naidu
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2016
Congestive heart failure: more common as well as an important cardiovascular outcomeAnil Pareek, Nitin Chandurkar, Shruti Dharmadhikari
The American Journal of Medicine|March 7, 2022
Risk vs Benefits of Thiazides in Clinical Use: Need for a Holistic ApproachAnil Pareek, Nitin Chandurkar, Shruti Dharmadhikari
Eye (London, England)|September 29, 2020
Hydroxychloroquine retinopathy-less than meets the eyeAnil Pareek, S Chandrashekara, Ravi T Mehta
Clinical Hypertension|March 7, 2018
Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparisonRavi Tejraj Mehta, Anil Pareek, Indranil Purkait
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Congestive heart failure: More common as well as an important cardiovascular outcomeAnil Pareek
Current Medical Research and Opinion|May 29, 2015
Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66Anil Pareek
Annals of the Rheumatic Diseases|December 24, 2016
Statin therapy now more common than steroids in clinical practiceAnil Pareek, Nitin Chandurkar
Current Medical Research and Opinion|April 16, 2013
Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritisAnil Pareek, Nitin Chandurkar
The Lancet. Diabetes & Endocrinology|January 3, 2016
Drug approvals in IndiaAnil Pareek, Nitin Chandurkar
The New England Journal of Medicine|November 3, 2016
Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesAnil Pareek, Nitin Chandurkar, Kumar Naidu
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2016
Congestive heart failure: more common as well as an important cardiovascular outcomeAnil Pareek, Nitin Chandurkar, Shruti Dharmadhikari
The American Journal of Medicine|March 7, 2022
Risk vs Benefits of Thiazides in Clinical Use: Need for a Holistic ApproachAnil Pareek, Nitin Chandurkar, Shruti Dharmadhikari
Eye (London, England)|September 29, 2020
Hydroxychloroquine retinopathy-less than meets the eyeAnil Pareek, S Chandrashekara, Ravi T Mehta
Clinical Hypertension|March 7, 2018
Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparisonRavi Tejraj Mehta, Anil Pareek, Indranil Purkait
Pageof 7